cbdMD, Inc.
YCBD
$0.49
-$0.01-1.56%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 20.93M | 19.98M | 19.09M | 19.19M | 19.03M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.93M | 19.98M | 19.09M | 19.19M | 19.03M |
| Cost of Revenue | 8.86M | 8.12M | 7.53M | 7.22M | 7.38M |
| Gross Profit | 12.07M | 11.87M | 11.57M | 11.97M | 11.64M |
| SG&A Expenses | 13.52M | 12.81M | 12.08M | 11.99M | 11.91M |
| Depreciation & Amortization | 1.02M | 1.04M | 1.07M | 1.13M | 1.15M |
| Other Operating Expenses | 411.00K | 662.80K | 745.20K | 978.80K | 332.50K |
| Total Operating Expenses | 23.83M | 22.66M | 21.46M | 21.35M | 20.82M |
| Operating Income | -2.90M | -2.68M | -2.36M | -2.16M | -1.79M |
| Income Before Tax | -2.89M | -2.66M | -2.34M | -2.04M | -1.51M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.89 | -2.66 | -2.34 | -2.04 | -1.51 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.89M | -2.66M | -2.34M | -2.04M | -1.51M |
| EBIT | -2.90M | -2.68M | -2.36M | -2.16M | -1.79M |
| EBITDA | -1.89M | -1.64M | -1.29M | -1.04M | -641.50K |
| EPS Basic | -0.31 | -0.41 | -2.23 | -3.92 | -5.05 |
| Normalized Basic EPS | -0.18 | -0.21 | -0.55 | -0.61 | -0.77 |
| EPS Diluted | -0.31 | -0.41 | -2.23 | -3.92 | -5.05 |
| Normalized Diluted EPS | -0.18 | -0.21 | -0.55 | -0.61 | -0.77 |
| Average Basic Shares Outstanding | 39.03M | 34.19M | 24.53M | 16.09M | 8.09M |
| Average Diluted Shares Outstanding | 39.03M | 34.19M | 24.53M | 16.09M | 8.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -4.17% | -- | -- | -- | -- |